Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan

Journal of Oral Pathology and Medicine

Volumn 33, Issue 4, 2004, Pages 209-217

  Chen, Yu Shan ^a   Wang, Jeng Tzung ^a,b   Chang, Yu Fong ^a,b   Liu, Bu Yuan ^a,b   Wang, Yi Ping ^a,b   Sun, Andy ^a,b   Chiang, Chun Pin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

c met protein; Hepatocyte growth factor; Oral cancer; Oral pre cancer

Indexed keywords

PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCULATION; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYTOPLASM; DISEASE PROGRESSION; EPITHELIUM; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; SURVIVAL RATE; TAIWAN;

EID: 1842785480     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0904-2512.2004.00118.x     Document Type: Article

References (44)

1. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol 2001; 13: 176-82.
2. Department of Health. The Executive Yuan. Taiwan, ROC: Cancer Registry Annual Report, ROC; 1990/2000.
3. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-3.
4. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc 1976; 75: 497-505.
5. Zeng Q, Chen S, You Z, et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFκB. J Biol Chem 2002; 277: 25203-8.
6. Bhargava MM, Li Y, Joseph A, Jin L, Rosen EM, Goldberg ID. HGF-SF: effects on motility and morphology of normal and tumor cells. EXS 1993; 65: 341-9.
7. Matsumoto K, Matsumoto K, Nakamura T, Kramer RH. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinases (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1994; 269: 31807-13.
8. Wong AS, Leung PC, Auersperg N. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells. Gynecol Oncol 2000; 78: 158-65.
9. Fan S, Ma YX, Wang JA, et al. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinases. Oncogene 2000; 19: 2212-23.
10. Gao M, Fan S, Goldberg ID, Laterra J, Kitsis RN, Rosen EM. Hepatocyte growth factor/scatter factor blocks the mitochondria pathway of apoptosis signaling in breast cancer cells. J Biol Chem 2001; 276: 47257-65.
11. Zeng Q, McCauley LK, Wang CY. Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression. J Biol Chem 2002; 277: 50137-42.
12. Rosen EM, Goldberg ID. Scatter factor and angiogenesis. Adv Cancer Res 1995; 67: 257-79.
13. Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Waes CV. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 2001; 61: 5911-8.
14. Michi Y, Morita I, Amagasa T, Murota S. Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. Oral Oncol 2000; 36: 81-8.
15. Weidner KM, Behrens J, Vandekerckhove J, et al. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990; 111: 2097-108.
16. Uchida D, Kawamata H, Omotehara F, et al. Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer 2001; 93: 489-96.
17. Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br J Cancer 1999; 80: 1708-17.
18. Shimabukuro K, Ichinose S, Koike R, et al. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer. Gynecol Oncol 2001; 83: 205-15.
19. Hanzawa M, Shindoh M, Higashino F, et al. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 2000; 21: 1079-85.
20. Bennett JH, Morgan MJ, Whawell SA, et al. Metalloproteinase expression in normal and malignant oral keratinocytes: stimulation of MMP-2 and -9 by scatter factor. Eur J Oral Sci 2000; 108: 281-91.
21. Tamura M, Arakaki N, Tsoubouchi H, et al. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem 1993; 268: 8140-5.
22. Sugiyama A, Arakaki R, Ohnishi T, Arakaki N, Daikuhara Y, Takada H. Lipoteichoic acid and interleukin 1 stimulate synergistically production of hepatocyte growth factor (scatter factor) in human gingival fibroblasts in culture. Infect Immun 1996; 64: 1426-31.
23. Moghul A, Lin L, Beedle A, et al. Modulation of c-met protooncogene mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8-kb c-met transcript. Oncogene 1994; 9: 2043-52.
24. Seol DW, Chen Q, Smith ML, Zarnegar R. Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem 1999; 274: 3565-72.
25. Naldini L, Tamagnone L, Vigna E, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992; 11: 4825-33.
26. Boccaccio C, Gaudino G, Gambarotta G, Galimi F, Comoglio PM. Hepatocyte growth factor (HGF) is inducible and is part of the delayed-early response to HGF. J Biol Chem 1994; 269: 12846-51.
27. Qian CN, Guo X, Cao B, et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 2002; 62: 589-96.
28. Takada N, Yano Y, Matsuda T, et al. Expression of immunoreactive human hepatocyte growth factor in human esophageal squamous cell carcinomas. Cancer Lett 1995; 97: 145-8.
29. Baykal C, Ayhan A, Al A, Yuce K, Ayhan A. Overexpression of the c-met/ HGF receptor and its prognostic significance in uterine cervix carcinomas. Gynnecol Oncol 2003; 88: 123-9.
30. Camp RL, Rimm EB, Rimm DL. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 1999; 86: 2259-65.
31. Kang JY, Dolled-Filhart M, Ocal IT, et al. Tissue microarray analysis of hepatocyte growth factor/met pathway components reveals a role for met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res 2003; 63: 1101-5.
32. Jin L, Fuchs A, Schnilt S, et al. Expression of SF and c-met receptor in benign and malignant breast tissue. Cancer 1997; 79: 749-60.
33. Ruco LP, Ranalli T, Marzullo A, et al. Expression of met protein in thyroid tumors. J Pathol 1996; 180: 266-70.
34. Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao MS. Hepatocyte growth factor and met receptor expression in human pancreatic carcinogenesis. Am J Pathol 1995; 147: 889-95.
35. Humphrey PA, Xiaopei Z, Zarnegar R, et al. Hepatocyte growth factor and its receptor (c-met) in prostatic carcinoma. Am J Pathol 1995; 147: 386-95.
36. Sawatsubashi M, Sasatomi E, Mizokami H, Tokunaga O, Shin T. Expression of c-Met in laryngeal carcinoma. Virch Arch 1998; 432: 331-5.
37. Marshall DD, Kornberg LJ. Overexpression of scatter factor and its receptor (c-met) in oral squamous cell carcinom. Laryngoscope 1998; 108: 1413-7.
38. Sobin LH, Wittekind C, (UICC) eds. TNM Classification of Malignant Tumors, 5th edn. New York: Weiley-Liss, 1997; 17-43.
39. Chiang CP, Huang JS, Wang JT, et al. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 72-6.
40. Kuo MYP, Huang JS, Hsu HC, et al. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 221-5.
41. Stephens P, Hiscox S, Cook H, Jiang WG, Zhiquiang W, Thomas DW. Phenotypic variation in the production of bioactive hepatocyte growth factor/scatter factor by oral mucosal and skin fibroblasts. Wound Repair Regen 2001; 9: 34-43.
42. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 3242-7.
43. Kolch W, Martiny-Baron G, Kieser A, Marme D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat 1995; 36: 139-55.
44. Morello S, Olivero M, Aimetti M, et al. MET receptor is overexpressed but not mutated in oral squamous cell carcinomas. J Cell Physiol 2001; 189: 285-90.